Nexthera Capital’s Verastem VSTM Stock Holding History

Nexthera Capital’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-28,000	Closed	-$696K	–	46
2017 Q1	$696K	Hold	28,000	–	–	0.36%	30
2016 Q4	$376K	Hold	28,000	–	–	0.22%	37
2016 Q3	$447K	Hold	28,000	–	–	0.27%	31
2016 Q2	$437K	Buy	+28,000	New	+$493K	0.38%	30

Other funds holding VSTM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nexthera Capital's VSTM Position: Q2 2017 in Review

Nexthera Capital sold out of Verastem (VSTM) in Q2 2017, closing a stake of 28,000 shares — an estimated $696K sold.

Nexthera Capital first reported a position in VSTM in Q2 2016 and held it in 4 quarters. The position peaked at $696K in Q1 2017. 59 funds tracked by Wall St. Rank hold VSTM as of Q2 2017.

Nexthera Capital reported no remaining Verastem position as of Q2 2017 after selling out during the quarter.
Nexthera Capital sold 28,000 Verastem shares in Q2 2017, an estimated $696K.
Nexthera Capital first reported a position in Verastem in Q2 2016 and held it in 4 quarters.
Nexthera Capital's Verastem position peaked at $696K in Q1 2017.
59 funds tracked by Wall St. Rank held Verastem as of Q2 2017.

Based on Nexthera Capital's 13F filing for Q2 2017, filed 14 Aug 2017.